Exploring program-cell death patterns to predict prognosis and sensitivity of cervical cancer immunotherapy via multi-omics analysis and clinical samples
This study establishes CDI as the PCD-based immune signature for CC, enabling precise prognosis prediction and ICI candidate selection. The CDI framework provides actionable insights for combination therapies targeting PCD-immune interplay, with translational potential for personalized oncology.
Authors
- Ying Luo (ORCID: https://orcid.org/0000-0002-1325-2296)
- Yongjin Luo (ORCID: https://orcid.org/0000-0002-2544-7058)
- Xianfeng Long
- Chunhong Pang
Institutions
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- The Second Nanning People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1007/s12672-025-02622-z
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00